Capella FPX 4045 Assessment 3

Evidence-Based Proposal and Annotated Bibliography on Technology in Nursing

Introduction to the Selected Technology Topic

Advancements in healthcare technology continue to transform patient care, particularly for individuals managing chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Among these innovations, smart watch providing vital signs and digital sensory-enabled inhalers have gained attention for enhancing treatment adherence, monitoring usage patterns, and providing real-time data to patients and healthcare providers (Kahnert et al., 2023). The following annotated bibliography explores the role of digital inhalers in managing asthma and COPD, two prevalent conditions that require strict adherence to treatment regimens.

The importance of this technology was highlighted during an analysis of Sentinel U simulation scenarios involving the character Lynn Tan, prompting a focused investigation into its clinical value. A systematic literature review was conducted using the Capella University Library and academic databases such as PubMed, CINAHL, and SpringerLink to gather relevant evidence. Keywords for the search included “digital inhalers,” “smart inhalers,” “COPD remote monitoring,” “asthma adherence technology,” and “inhaler sensors in nursing care.” The final selection included peer-reviewed articles from the past five years, specifically examining the impact of digital inhalers on the management of asthma and COPD in clinical settings.

Assumptions

It is assumed that digital inhalers have the potential to significantly enhance treatment adherence and real-time disease monitoring for patients with asthma and COPD. The reviewed literature operates on the premise that technological innovations in inhaler design can improve clinical outcomes. Additionally, it is assumed that healthcare providers are progressively incorporating smart inhalers into chronic respiratory care as part of a broader shift toward digital health solutions.

Annotation Elements

Anticevich, S., Bakerly, N. D., Chrystyn, H., Hew, M., & Palen, J. (2023). Advancing digital solutions to overcome longstanding barriers in asthma and COPD management. Patient Preference and Adherence, 17, 259–272. https://doi.org/10.2147/ppa.s385857 

The research focused on a scientific evaluation of smartwatches used for managing asthma and COPD by continuously monitoring vital signs. It examined the technological capabilities of these devices, including real-time tracking of physiological data, automatic transmission to healthcare providers, and the monitoring of patient adherence to care plans. Smartwatches play a vital role in patient safety by helping detect early signs of exacerbations and promoting consistent self-management. These devices support better disease control and improved patient outcomes, ultimately contributing to higher quality of care.

For nurses, smartwatches provide valuable clinical data that support personalized care and ongoing respiratory health monitoring. This technology also enhances interdisciplinary collaboration by improving communication and coordination between patients and providers. The study was selected because it offers comprehensive research on the application of wearable technology in chronic disease management and its significance in advancing modern healthcare practices. It provides essential evidence for healthcare professionals seeking to optimize care strategies for individuals with asthma and COPD.

Capella FPX 4045 Assessment 3

Eikholt, A. A., Hew, M., & Boven, van. (2023). Electronic monitoring devices to support inhalation technique in patients with asthma: A narrative review. Curr Treat Options Allergy, 10(1), 28–52. https://doi.org/10.1007/s40521-023-00328-7 

This article reviews the role of electronic monitoring devices (EMDs) in assessing and improving patient inhalation technique, a critical factor often linked to poor outcomes in individuals with chronic respiratory conditions. The study identified six EMDs capable of detecting inhaler technique errors, varying in features such as sensor types, feedback mechanisms, and sustainability, with unit costs ranging between $100 and $500.

These devices provide reliable tracking of inhalation errors, support patient education, and act as early warning systems for exacerbations. However, gaps remain in understanding patient preferences, cost-effectiveness, and the clinical impact of such monitoring. For successful implementation in clinical practice, nursing professionals must consider reimbursement challenges and the balance between device costs and potential savings from improved adherence and reduced healthcare utilization. This article was chosen for its detailed exploration of both the technological capabilities of EMDs and the practical considerations affecting their adoption in patient care.

Capella FPX 4045 Assessment 3

Mosnaim, G. S., Greiwe, J., Jariwala, S. P., Pleasants, R., & Merchant, R. (2022). Digital inhalers and remote patient monitoring for asthma. The Journal of Allergy and Clinical Immunology: In Practice, 10(10), 2525–2533. https://doi.org/10.1016/j.jaip.2022.06.026 

The study evaluated digital remote maintenance programs to boost inhaler adherence among COPD patients. Several studies contributed their results to the publication, which examined the benefits of digital intervention for patient medication adherence and clinical outcomes. This research proved that digital intervention platforms improve patient safety outcomes through their actions in preventing inhaler misuse and improving patient treatment compliance. Better adherence rates lead to improved symptom control, decreased exacerbations, and superior quality care.

The nursing practice utilizes digital remote adherence interventions to deliver real-time medication use data, enabling healthcare staff to modify treatment plans promptly. The interdisciplinary group can better work together to handle COPD patients using these mobile devices. This publication was chosen because it examines digital health approaches to manage COPD patient adherence, since adherence is essential in improving final patient outcomes. Evidence-based strategies for patient care improvement and adherence are vital for healthcare practitioners because of the research findings.

Long, H., Li, S., & Chen, Y. (2023). Digital health in chronic obstructive pulmonary disease. Chronic Diseases and Translational Medicine, 9(2), 90–103. https://doi.org/10.1002/cdt3.68 

Capella FPX 4045 Assessment 3

This research examined the process of using digital inhalers to treat asthma and COPD patients. The authors analyzed the advantages and difficulties of using these medical devices to support patient drug compliance, healthcare tracking, and service quality improvement. Digital inhalers boost patient safety through their capacity to deliver real-time usage information about inhaler usage, which decreases medication errors while promoting strict adherence to treatment plans. The improved care outcomes for asthma and COPD patients arise from advanced disease management, which produces fewer severe flare-ups and better long-term health results.

Using digital inhalers by nurses creates valuable opportunities to track patient development and verify that patients follow their medically prescribed treatment. The digital inhalers establish combined care management between interdisciplinary healthcare staff by enabling quick team interactions. This practical study was selected because it presents guidelines for digital inhaler integration in clinical practice. This publication provides crucial information about technology-enhanced patient outcomes to healthcare professionals who must use it as their fundamental tool for respiratory care evolution.

Artificial Intelligence

Artificial Intelligence (AI) has the potential to significantly improve the functionality of digital inhalers by interpreting real-time data from devices such as inhalers and spirometers to monitor adherence and anticipate potential exacerbations. By recognizing behavioral patterns and trends in usage, AI-driven systems can support the development of personalized care strategies tailored to each patient’s needs. For instance, AI can notify healthcare professionals when a patient skips doses or shows signs of worsening symptoms, allowing for prompt and targeted interventions. As Long et al. (2023) noted, integrating AI with digital inhaler technology enhances clinical oversight, streamlines nursing tasks, and promotes patient safety through early, data-informed care adjustments. This synergy ultimately boosts both the effectiveness and efficiency of chronic respiratory care.

Ramachandran, H., Oh, J. L., Cheong, Y. K., Jiang, Y., Teo, J. Y. C., Seah, C. W. A., Yu, M., & Wang, W. (2023). Barriers and facilitators to the adoption of digital health interventions for COPD management: A scoping review. Heart & Lung, 59, 117–127. https://doi.org/10.1016/j.hrtlng.2023.02.004 

Capella FPX 4045 Assessment 3

This study explored single-inhaler triple therapy and digital inhaler adherence in patients with COPD, emphasizing how smart inhalers improve medication compliance and influence clinical outcomes in disease management. The evidence highlights that digital inhalers enhance patient safety by ensuring accurate medication delivery and real-time tracking, contributing to more effective COPD control.

These tools help improve patients’ quality of life by reducing hospitalizations and exacerbations. In nursing practice, digital inhalers serve as valuable resources for data monitoring and patient education, promoting stronger communication between healthcare professionals and their patients. Tracking inhaler usage allows nurses to tailor interventions and foster interdisciplinary collaboration. This article was selected to examine both clinical impacts and practical implementation, shedding light on the barriers and facilitators involved in integrating digital health tools into COPD care.

Summary of Recommendations

The findings from these five publications demonstrate how digital inhalers improve healthcare quality through safe patient practices and improve nursing workflow system performance. Real-time patient adherence tracking and symptom monitoring are possible through AI integration with digital inhalers (Long et al., 2023; Mosnaim et al., 2022). These medical devices provide important data to interdisciplinary healthcare teams that allow them to develop personalized care plans for individual patients (Eikholt et al., 2023). Research on digital inhalers demonstrates their ability to enhance clinical patient results and boost healthcare operational effectiveness (Anticevich et al., 2023). The digital monitoring devices enable communication between various team members, creating greater care quality integration through improved staff collaboration.

When selecting digital inhalers as technology for healthcare use, organizational elements such as policies, resource availability, cultural aspects, and training initiatives must be carefully considered. The successful implementation of new devices depends heavily on the organizational backing of training programs and staff familiarity with technology and culture that promotes innovation. Healthcare organizations need complete leadership support, explicit guidelines for data protection and patient tracking systems, and new technology adoption policies.

Digital inhalers improve patient satisfaction and the management of chronic diseases such as COPD and asthma, respectively (Ramachandran et al., 2023). Research shows that digital inhalers produce better patient treatment results while simultaneously reducing hospital admissions rates and enabling healthcare teams and patients to become more independent, thus making them an essential healthcare tool for current systems (Ramachandran et al., 2023). Healthcare staff experience improved professional satisfaction rates and reduced employee turnover because modern technologies enhance collaborative workflows.

References

Anticevich, S., Bakerly, N. D., Chrystyn, H., Hew, M., & Palen, J. (2023). Advancing digital solutions to overcome longstanding barriers in asthma and COPD management. Patient Preference and Adherence, 17, 259–272. https://doi.org/10.2147/ppa.s385857 

Eikholt, A. A., Hew, M., & Boven, van. (2023). Electronic monitoring devices to support inhalation technique in patients with asthma: A narrative review. Curr Treat Options Allergy, 10(1), 28–52. https://doi.org/10.1007/s40521-023-00328-7 

Kahnert, K., Jörres, R. A., Behr, J., & Welte, T. (2023). The diagnosis and treatment of COPD and its comorbidities. PubMed, 120(25), 434–444. https://doi.org/10.3238/arztebl.m2023.027 

Long, H., Li, S., & Chen, Y. (2023). Digital health in chronic obstructive pulmonary disease. Chronic Diseases and Translational Medicine, 9(2), 90–103. https://doi.org/10.1002/cdt3.68 

Mosnaim, G. S., Greiwe, J., Jariwala, S. P., Pleasants, R., & Merchant, R. (2022). Digital inhalers and remote patient monitoring for asthma. The Journal of Allergy and Clinical Immunology: In Practice, 10(10), 2525–2533. https://doi.org/10.1016/j.jaip.2022.06.026 

Ramachandran, H., Oh, J. L., Cheong, Y. K., Jiang, Y., Teo, J. Y. C., Seah, C. W. A., Yu, M., & Wang, W. (2023). Barriers and facilitators to the adoption of digital health interventions for COPD management: A scoping review. Heart & Lung, 59, 117–127. https://doi.org/10.1016/j.hrtlng.2023.02.004